These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32823395)

  • 41. Immune recovery uveitis in a patient with previously undiagnosed cytomegalovirus retinitis.
    Rangel CM; Prada AM; Varon C; Merayo-Lloves J
    BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26531739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Ophthalmological findings in HIV infected patients in the post-HAART (Highly Active Anti-retroviral Therapy) era, compared to the pre-HAART era].
    Arruda RF; Muccioli C; Belfort R
    Rev Assoc Med Bras (1992); 2004; 50(2):148-52. PubMed ID: 15286861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy.
    Deayton JR; Wilson P; Sabin CA; Davey CC; Johnson MA; Emery VC; Griffiths PD
    AIDS; 2000 Jun; 14(9):1163-70. PubMed ID: 10894280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new acronym, a new threat: IRU.
    Proj Inf Perspect; 1999 Sep; (28):11. PubMed ID: 11367354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodeficiency virus / acquired immune deficiency syndrome.
    Venkatesh KK; Biswas J; Kumarasamy N
    Indian J Ophthalmol; 2008; 56(5):391-3. PubMed ID: 18711267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug-induced Uveitis in HIV Patients with Ocular Opportunistic Infections.
    Testi I; Agarwal A; Agrawal R; Mahajan S; Marchese A; Miserocchi E; Gupta V
    Ocul Immunol Inflamm; 2020 Oct; 28(7):1069-1075. PubMed ID: 31850816
    [No Abstract]   [Full Text] [Related]  

  • 47. [Diagnosis and treatment of eye diseases associated with HIV infection and AIDS].
    Geng S; Ye JJ; Liu LQ; Xu HY; Wang WW; Wang SR
    Zhonghua Yan Ke Za Zhi; 2009 Dec; 45(12):1093-8. PubMed ID: 20193432
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Two types of CMV ocular complications in patients with HIV infection].
    Kozner P; Rozsypal H; Machala L; Filous A; Brozek B
    Klin Mikrobiol Infekc Lek; 2009 Oct; 15(5):180-2. PubMed ID: 19916157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medical management of human immunodeficiency virus infection.
    Kempen JH
    Indian J Ophthalmol; 2008; 56(5):385-90. PubMed ID: 18711266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seven years of HAART impact on ophthalmic management of HIV-infected patients.
    Kahraman G; Krepler K; Franz C; Ries E; Maar N; Wedrich A; Rieger A; Dejaco-Ruhswurm I
    Ocul Immunol Inflamm; 2005; 13(2-3):213-8. PubMed ID: 16019681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy.
    Jabs DA; Ahuja A; Van Natta M; Dunn JP; Yeh S;
    Ophthalmology; 2013 Jun; 120(6):1262-70. PubMed ID: 23419804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era.
    Lai TY; Wong RL; Luk FO; Chow VW; Chan CK; Lam DS
    Clin Exp Ophthalmol; 2011 Mar; 39(2):99-104. PubMed ID: 20796263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lower incidence and severity of cytomegalovirus-associated immune recovery uveitis in HIV-infected patients with delayed highly active antiretroviral therapy.
    Ortega-Larrocea G; Espinosa E; Reyes-Terán G
    AIDS; 2005 Apr; 19(7):735-8. PubMed ID: 15821403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical and paraclinical features of syphilitic uveitis].
    Marty AS; Cornut PL; Janin-Manificat H; Perard L; Debats F; Burillon C
    J Fr Ophtalmol; 2015 Mar; 38(3):220-8. PubMed ID: 25637233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune recovery uveitis: pathogenesis, clinical symptoms, and treatment.
    Urban B; Bakunowicz-Łazarczyk A; Michalczuk M
    Mediators Inflamm; 2014; 2014():971417. PubMed ID: 25089078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intraocular viral and immune pathogenesis of immune recovery uveitis in patients with healed cytomegalovirus retinitis.
    Schrier RD; Song MK; Smith IL; Karavellas MP; Bartsch DU; Torriani FJ; Garcia CR; Freeman WR
    Retina; 2006 Feb; 26(2):165-9. PubMed ID: 16467672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of highly active antiretroviral therapy (HAART) on the natural history of ocular manifestations in HIV-infected children.
    Esposito S; Porta A; Bojanin J; Gualtieri L; Cesati L; Vismara E; Principi N
    Eye (Lond); 2006 May; 20(5):595-7. PubMed ID: 16410815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Ocular immune reconstitution inflammatory syndrome].
    Ma N; Ye JJ
    Zhonghua Yan Ke Za Zhi; 2016 Feb; 52(2):150-3. PubMed ID: 26906710
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ocular Manifestations of Human Immunodeficiency Virus Infection at a Tertiary Referral Center in Taiwan.
    Tsen CL; Chen YS; Wu KS; Tsai HC; Chen YH; Lee YY; Sheu SJ
    Ocul Immunol Inflamm; 2019; 27(7):1071-1076. PubMed ID: 30189150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.